Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.

@article{Tadimety2018AdvancesIL,
  title={Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.},
  author={Amogha Tadimety and Andrew B. Closson and Cathy S Li and S. A. Yi and Ting Shen and John X. J. Zhang},
  journal={Critical reviews in clinical laboratory sciences},
  year={2018},
  volume={55 3},
  pages={
          140-162
        }
}
Liquid biopsy, as a minimally invasive method of gleaning insight into the dynamics of diseases through a patient fluid sample, has been growing in popularity for cancer diagnosis, prognosis, and monitoring. While many technologies have been developed and validated in research laboratories, there has also been a push to expand these technologies into other clinical settings and as point of care devices. In this article, we discuss and evaluate microchip-based technologies for circulating tumor… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.
3 Citations
115 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 115 references

Clinical and biological significance of circulating tumor cells , circulating tumor DNA , and exosomes as biomarkers in colorectal can

  • Z Lv
  • Oncotarget .
  • 2017

Similar Papers

Loading similar papers…